How to identify patients with vulnerable plaques

Area of Science:

• Cardiology
• Preventive Medicine
• Medical Diagnostics

Background:

• Cardiovascular events pose a significant health burden.
• Identifying high-risk patients is crucial for effective prevention strategies.
• Current methods include plaque identification and patient assessment.

Purpose of the Study:

• To review the utility and limitations of global risk assessment tools for identifying vulnerable patients.
• To discuss the role of biomarkers and non-invasive measures in risk stratification.
• To provide a comprehensive overview of strategies for high-risk cardiovascular event identification.

Main Methods:

• Literature review of clinical strategies for cardiovascular risk assessment.
• Analysis of global risk assessment tools.
• Evaluation of biomarkers: C-reactive protein, lipoprotein-associated phospholipase A(2), lipoprotein(a).
• Assessment of non-invasive measures: coronary artery calcium scores, carotid intima-media thickness, ankle-brachial index.

Main Results:

• Vulnerable patient identification is less invasive and broadly applicable compared to vulnerable plaque identification.
• Global risk assessment tools offer a practical approach to identifying at-risk individuals.
• Biomarkers and non-invasive measures provide valuable, complementary data for risk stratification.

Conclusions:

• Identifying vulnerable patients is a key strategy in cardiovascular event prevention.
• A combination of global risk assessment, biomarkers, and non-invasive imaging enhances risk identification.
• These approaches aid clinicians in managing patients at high risk for cardiovascular events.